Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Discovery and Intelligence

How to Integrate Artificial Intelligence in Drug Discovery: The Future of Pharmaceuticals

Explore the role of AI in drug discovery, from target identification to clinical trials. Discover the benefits challenges of pharma research.

Pubrica AcademyWritten by the medical writing and biostatistics teamsPublished14 July 2025Updated25 November 2025Reading time3 minutes
  • Home
  • Academy
  • Discovery & Intelligence Services
  • How to Integrate Artificial Intelligence in Drug Discovery

Table of Content

1. The Role of AI in Drug Discovery
2. Benefits of AI in Drug Discovery
3. AI Applications and Tools in Different Phases of Drug Discovery
4. Different Applications of AI in Drug Discovery and Development
5. Challenges and Limitations of AI in Drug Discovery
6. Conclusion

With the integration of data, computational power, and algorithms, Artificial Intelligence (AI) is changing the traditional drug discovery and development model. This synergistic collaboration enhances the efficiency, accuracy, and success of drug research while reducing development times and costs. Together with machine learning (ML) and deep learning (DL), AI has made great strides in many areas of drug research, including drug characterization, target discovery and validation, small molecule drug design, and clinical trial acceleration. Specifically utilizing molecular generation approaches. [1]

This article outlines the effective use of how to integrate artificial intelligence in drug discovery future of pharmaceuticals, including the role of AI in drug discovery and the benefits of AI in drug discovery.

1.The Role of AI in Drug Discovery

1.1. Data-Driven Insights: Using AI for Predictive Modeling

  • AI accepts large-scale data (genomic, proteomic, chemical) and can identify patterns faster than traditional algorithms.
  • AI algorithms, for example, machine learning (ML) or deep learning (DL), can make predictions about molecular activity, toxicity, and efficacy.

1.2. Drug Target Identification and Validation

    • AI accelerates the identification of potential.
    • Finding the right drug targets is an important part of the drug discovery process as it defines a biological pathway and molecular mechanisms, and can be targeted to produce some therapeutic effect.
    • Identification of targets is critically enabled by machine learning algorithms that enable evaluation of complex datasets of genomic, proteomic, and clinical data, to identify potential disease-associated targets and prioritize the targets that warrant further investigation.[2]

1.3. Virtual Screening and Compound Optimization

AI plays a crucial role in virtual screening for chemical libraries, optimizing compounds for better bioavailability and reducing side effects.

2. Benefits of AI in Drug Discovery

2.1. Efficiency and Speed

AI enhances efficiency and speed in drug discovery by automating time-consuming tasks like screening and data analysis.

2.2. Cost Reduction

AI enhances the success rate of failed drug trials by utilizing predictive analytics to reduce the financial burden.

3. AI Applications and Tools in Different Phases of Drug Discovery

PhaseAI ApplicationAI Tools Used
Target IdentificationAI helps in identifying potential biological targets for drug development by analysing genomic and proteomic data.Insilico Medicine, BenevolentAI
Compound ScreeningVirtual screening through AI-driven simulations to identify promising drug candidates from large libraries.Atomwise, DeepChem
Preclinical TestingAI models predict drug toxicity, bioavailability, and side effects based on molecular structure.Schrodinger, Labcorp Drug Development
Clinical TrialsAI improves patient selection and monitors real-time data during trials to predict drug efficacy and safety.IBM Watson Health, Tempus

4. Different Applications of AI in Drug Discovery and Development

gfw4erkwjqmhgwsqri1w-scaled

Figure 1: Uses of artificial intelligence (AI) in the various subfields in the pharmaceutical industry, from drug discovery to management of pharmaceutical products. Image adapted from Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021). Artificial intelligence in drug discovery and development. Drug Discovery Today, 26(1), 80–93. https://doi.org/10.1016/j.drudis.2020.10.010

5. Challenges and Limitations of AI in Drug Discovery

Despite the promising potential, there are several challenges to integrating AI in drug discovery:[4]

  • Data Quality and Availability: With AI models, it is important to have a large and high-quality dataset to train the models effectively. Access to this kind of data is often not available when conducting pharmaceutical research.[5]
  • Interpretability: Many AI models, especially deep learning models, are treated as “black boxes,” meaning that they are hard to reason about and to understand their decision process. This “black box” effect can present an additional challenge for regulatory approval.
  • Regulatory Hurdles: The pharmaceutical industry is heavily regulated, and the use of AI in drug discovery will have to adhere to regulatory standards. There can be concerns about how AI-based decisions would be validated and accepted by regulators, such as the FDA.

Conclusion

Pharmaceutical and drug discovery are being transformed through the utilization of AI. Pharmaceutical manufacturers are able to employ machine learning, deep learning, and all other forms of AI for drug discovery in a number of different ways; faster, cheaper, and ultimately for improving patient outcomes. As AI technology continues to improve, drug discovery will transform across the lifespan of drug discovery and commercialization.

Unlock the potential of AI in drug discovery. Explore our expert services to accelerate your pharmaceutical research today!

Need support with this?

Pubrica’s writers, editors and statisticians work with authors on discovery and intelligence and related publication tasks. The authors keep ownership of the work and responsibility for its content. Talk to the team.

References

  1. Serrano, D. R., Luciano, F. C., Anaya, B. J., Ongoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., Rapti, C., Ruiz, H. K., Rawat, S., Kumar, D., & Lalatsa, A. (2024). Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine. Pharmaceutics, 16(10), 1328. https://doi.org/10.3390/pharmaceutics16101328
  2. Brinkhaus, H. O., Rajan, K., Schaub, J., Zielesny, A., & Steinbeck, C. (2023). Open data and algorithms for open science in AI-driven molecular informatics. Current opinion in structural biology, 79, 102542. https://doi.org/10.1016/j.sbi.2023.102542
  3. Kant, S., Deepika & Roy, S. Artificial intelligence in drug discovery and development: transforming challenges into opportunities. Pharm. Sci.1, 7 (2025). https://doi.org/10.1007/s44395-025-00007-3
  4. Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023). The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies. Pharmaceuticals (Basel, Switzerland), 16(6), 891. https://doi.org/10.3390/ph16060891
  5. Kokudeva, M., Vichev, M., Naseva, E., Miteva, D. G., & Velikova, T. (2024). Artificial intelligence as a tool in drug discovery and development. World Journal of Experimental Medicine, 14(3), 96042. https://doi.org/10.5493/wjem.v14.i3.96042
  6. Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021). Artificial intelligence in drug discovery and development. Drug Discovery Today, 26(1), 80–93. https://doi.org/10.1016/j.drudis.2020.10.010
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.